Hsbc Holdings PLC Acquires 318,146 Shares of Omega Healthcare Investors, Inc. $OHI

Key Points

• HSBC increased its Omega Healthcare Investors stake by 52.3% in the second quarter, adding 318,146 shares for a total of 926,367 shares valued at approximately $44.4 million. Institutional investors collectively own 65.25% of OHI.
• Analysts maintain a consensus “Hold” rating with an average price target of $49.50; ratings include six Buys, seven Holds, and two Sells.
• Omega reported quarterly revenue of $328.25 million and EPS of $1.19, exceeding estimates, while raising its quarterly dividend to $0.68, equivalent to a 5.9% annualized yield.

Hsbc Holdings PLC increased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 52.3% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 926,367 shares of the real estate investment trust's stock after purchasing an additional 318,146 shares during the period. Hsbc Holdings PLC owned approximately 0.31% of Omega Healthcare Investors worth $44,398,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. BlackRock Inc. bought a new stake in Omega Healthcare Investors in the second quarter worth $1,838,155,000. Bank of New York Mellon Corp purchased a new stake in Omega Healthcare Investors during the second quarter valued at about $275,230,000. Norges Bank bought a new position in shares of Omega Healthcare Investors during the fourth quarter valued at about $156,166,000. Bank of America Corp DE bought a new position in shares of Omega Healthcare Investors during the second quarter valued at about $137,876,000. Finally, Invesco Ltd. increased its holdings in shares of Omega Healthcare Investors by 101.7% in the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust's stock worth $208,775,000 after buying an additional 2,493,877 shares during the period. Institutional investors own 65.25% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company lowered their target price on Omega Healthcare Investors from $49.00 to $48.00 and set an "equal weight" rating for the company in a research note on Tuesday, September 1st. Cantor Fitzgerald raised their price target on Omega Healthcare Investors from $52.00 to $56.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Truist Financial decreased their price target on Omega Healthcare Investors from $48.00 to $46.00 and set a "hold" rating on the stock in a research note on Tuesday, June 9th. Barclays decreased their price target on Omega Healthcare Investors from $51.00 to $50.00 and set an "underweight" rating on the stock in a research note on Monday, August 31st. Finally, Mizuho increased their price objective on Omega Healthcare Investors from $45.00 to $46.00 and gave the company a "neutral" rating in a research note on Monday, August 31st. Six research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Omega Healthcare Investors currently has an average rating of "Hold" and a consensus price target of $49.50.

Omega Healthcare Investors Trading Up 0.1%

Shares of OHI opened at $46.41 on Tuesday. Omega Healthcare Investors, Inc. has a 1-year low of $39.26 and a 1-year high of $52.39. The firm's 50-day moving average price is $48.28 and its 200-day moving average price is $47.08. The firm has a market capitalization of $14.06 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.88 and a beta of 0.58.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.51 by $0.68. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The company had revenue of $328.25 million during the quarter, compared to the consensus estimate of $266.97 million. During the same period in the prior year, the firm earned $0.77 earnings per share. Omega Healthcare Investors's revenue was up 16.2% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, research analysts forecast that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, August 3rd were given a $0.68 dividend. The ex-dividend date of this dividend was Monday, August 3rd. This represents a $2.72 annualized dividend and a dividend yield of 5.9%. This is an increase from Omega Healthcare Investors's previous quarterly dividend of $0.67. Omega Healthcare Investors's dividend payout ratio is currently 97.14%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.